{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Christopher Gerner"}, {"accession": "MS:1000589", "name": "contact email", "value": "christopher.gerner@univie.ac.at"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Vienna"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Christopher Gerner"}, {"accession": "MS:1000589", "name": "contact email", "value": "christopher.gerner@univie.ac.at"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry"}]}], "datasetFiles": [{"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_1_1.mgf"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_1_1.mzid.gz"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_1_1.raw"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_1_2.mgf"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_1_2.mzid.gz"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_1_2.raw"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_2_1.mgf"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_2_1.mzid.gz"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_2_1.raw"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_2_2.mgf"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_2_2.mzid.gz"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389/HCT116_pulldown_normal_4h_2_2.raw"}], "description": "The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an organometallic ruthenium(II) scaffold, as selective plectin-targeting agents. Plectin is a giant scaffold protein involved in controlling cytoarchitecture. Subcytotoxic concentrations of plestatins induce drastic morphological phenotypes on the microtubule (MT) network accompanied by a global down-regulation of translational activity. Plestatins possess anti-invasive properties in tumour spheroids and also display tumour-inhibiting effects in vivo after oral administration. The ability of plestatins to alter the MT network via plectin represents a unique mechanism to target MTs and shows promise as an anticancer strategy.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD005389"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD005389"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD005389"}, {"accession": "MS:1001922", "name": "Digital Object Identifier (DOI)", "value": "10.6019/PXD005389"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Chemical Proteomics, Mechanism of Action, Metallodrugs, Organometallics, Plectin, Ruthenium, Response Profiling, Target Identification"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "UNIMOD:35", "name": "Oxidation"}, {"accession": "UNIMOD:1", "name": "Acetyl"}, {"accession": "UNIMOD:4", "name": "Carbamidomethyl"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "28547791"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Meier SM, Kreutz D, Winter L, Klose MHM, Cseh K, Weiss T, Bileck A, Alte B, Mader JC, Jana S, Chatterjee A, Bhattacharyya A, Hejl M, Jakupec MA, Heffeter P, Berger W, Hartinger CG, Keppler BK, Wiche G, Gerner C. An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin. Angew Chem Int Ed Engl. 2017 May 26"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Targeting the Scaffold Protein Plectin by an Organometallic as a Strategy to Inhibit Tumour Invasiveness- whole cell lysate of HCT 116 epithelial cells, plestatins-3 normal pull down 4h"}